IP Library Granted Patent US 7,825,105
Granted Patent B2
US 7,825,105 · App. 11/069,197 · Granted Nov 2, 2010

3, 10, and 12a substituted tetracycline compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,825,105
App. No.
11/069,197
Granted
Nov 2, 2010
Kind
B2
Abstract

The present invention pertains to novel 3, 10, and/or 12a-substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.

Claims (57)

1. A compound of Formula I:

wherein:

X is CHC(R 13 Y′Y) or CR 6′ R 6 ;

R 2″ is —C(═O)NR 2 R 2′ or —CN;

R 2 , R 2′ , R 4a , and R 4b are each independently hydrogen, alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, arylalkyl, aryl, heterocyclic, heteroaromatic or a prodrug moiety;

R 3 , R 10 , R 11 , R 12 , and R 12″ are each independently hydrogen, alkyl, alkenyl, aryl, alkynyl, arylalkyl, acetyl, alkylcarbonyl, alkenylcarbonyl, arylcarbonyl, alkynylcarbonyl, alkyloxycarbonyl, alkenyloxycarbonyl, alkynyloxycarbonyl, aryloxycarbonyl, alkylaminocarbonyl, alkenylaminocarbonyl, alkynylaminocarbonyl, arylaminocarbonyl, alkylthiocarbonyl, alkenylthiocarbonyl, alkynylthiocarbonyl, arylthiocarbonyl, alkyloxythiocarbonyl, alkenyloxythiocarbonyl, alkynyloxythiocarbonyl, aryloxythiocarbonyl, alkylaminothiocarbonyl, alkenylaminothiocarbonyl, alkynylaminothiocarbonyl, arylaminothiocarbonyl, alkylthiothiocarbonyl, alkenylthiothiocarbonyl, alkynylthiothiocarbonyl, arylthiothiocarbonyl, provided that at least one of R 3 , R 10 , R 11 , or R 12 is not hydrogen when R 2″ is —C(═O)NR 2 R 2′ and R 12′ is OR 12 ;

R 4 and R 4′ are each independently NR 4a R 4b , alkyl, alkenyl, alkynyl, hydroxyl, halogen, hydrogen, or when taken together the oxygen of a carbonyl group;

R 5 is hydroxyl, hydrogen, thiol, alkanoyl, aroyl, alkaroyl, aryl, heteroaromatic, alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, arylalkyl, alkyl carbonyloxy, or aryl carbonyloxy;

R 6 and R 6′ are each independently hydrogen, methylene, absent, hydroxyl, halogen, thiol, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, or arylalkyl;

R 7 is amino;

R 8 is hydrogen;

R 9 is hydrogen;

R 12′ is OR 12 or NR 12 R 12″ ;

R 13 is hydrogen, hydroxy, alkyl, alkenyl, alkynyl, alkoxy, alkylthio, aryl, alkylsulfinyl, alkylsulfonyl, alkylamino, or arylalkyl;

Y′ and Y are each independently hydrogen, halogen, hydroxyl, cyano, sulfhydryl, amino, alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, or arylalkyl; or a pharmaceutically acceptable salt, ester or enantiomer thereof.

2. The compound of claim 1 , wherein X is CR 6 R 6′ ; R 2 , R 2′ , R 6 , R 6′ , R 8 and R 11 are each hydrogen; and R 5 is hydroxyl or hydrogen.

3. The compound of claim 2 , wherein R 4 dialkylamino, and R 4′ and R 5 are each hydrogen.

4. The compound of any one of claim 1 , wherein R 3 is alkyl, alkenyl, aryl, acetyl, arylalkyl, alkynyl, alkylcarbonyl, alkenylcarbonyl, arylcarbonyl, alkynylcarbonyl, alkyloxycarbonyl, alkenyloxycarbonyl, alkynyloxycarbonyl, aryloxycarbonyl, alkylaminocarbonyl, alkenylaminocarbonyl, alkynylaminocarbonyl, arylaminocarbonyl, alkylthiocarbonyl, alkenylthiocarbonyl, alkynylthiocarbonyl, arylthiocarbonyl, alkyloxythiocarbonyl, alkenyloxythiocarbonyl, alkynyloxythiocarbonyl, aryloxythiocarbonyl, alkylaminothiocarbonyl, alkenylaminothiocarbonyl, alkynylaminothiocarbonyl, arylaminothiocarbonyl, alkylthiothiocarbonyl, alkenylthiothiocarbonyl, alkynylthiothiocarbonyl, or arylthiothiocarbonyl.

5. The compound of claim 4 , wherein R 3 is arylalkyl.

6. The compound of claim 5 , wherein R 3 is benzyl.

7. The compound of claim 4 , wherein R 3 is alkyl.

8. The compound of claim 4 , wherein R 3 is acetyl.

9. The compound of claim 4 , wherein R 3 is alkenyl.

10. The compound of claim 1 , wherein R 3 is hydrogen.

11. The compound of claim 1 , wherein R 10 is alkyl, alkenyl, aryl, acetyl, arylalkyl, alkynyl, alkylcarbonyl, alkenylcarbonyl, arylcarbonyl, alkynylcarbonyl, alkyloxycarbonyl, alkenyloxycarbonyl, alkynyloxycarbonyl, aryloxycarbonyl, alkylaminocarbonyl, alkenylaminocarbonyl, alkynylaminocarbonyl, arylaminocarbonyl, alkylthiocarbonyl, alkenylthiocarbonyl, alkynylthiocarbonyl, arylthiocarbonyl, alkyloxythiocarbonyl, alkenyloxythiocarbonyl, alkynyloxythiocarbonyl, aryloxythiocarbonyl, alkylaminothiocarbonyl, alkenylaminothiocarbonyl, alkynylaminothiocarbonyl, arylaminothiocarbonyl, alkylthiothiocarbonyl, alkenylthiothiocarbonyl, alkynylthiothiocarbonyl, or arylthiothiocarbonyl.

12. The compound of claim 11 , wherein R 10 is arylalkyl.

13. The compound of claim 12 , wherein R 10 is benzyl.

14. The compound of claim 11 , wherein R 10 is alkyl.

15. The compound of claim 11 , wherein R 10 is acetyl.

16. The compound of claim 11 , wherein R 10 is alkenyl.

17. The compound of claim 1 , wherein R 10 is hydrogen.

18. The compound of claim 1 , wherein R 12 is alkyl, alkenyl, aryl, acetyl, arylalkyl, alkynyl, alkylcarbonyl, alkenylcarbonyl, arylcarbonyl, alkynylcarbonyl, alkyloxycarbonyl, alkenyloxycarbonyl, alkynyloxycarbonyl, aryloxycarbonyl, alkylaminocarbonyl, alkenylaminocarbonyl, alkynylaminocarbonyl, arylaminocarbonyl, alkylthiocarbonyl, alkenylthiocarbonyl, alkynylthiocarbonyl, arylthiocarbonyl, alkyloxythiocarbonyl, alkenyloxythiocarbonyl, alkynyloxythiocarbonyl, aryloxythiocarbonyl, alkylaminothiocarbonyl, alkenylaminothiocarbonyl, alkynylaminothiocarbonyl, arylaminothiocarbonyl, alkylthiothiocarbonyl, alkenylthiothiocarbonyl, alkynylthiothiocarbonyl, or arylthiothiocarbonyl.

19. The compound of claim 18 , wherein R 12 is arylalkyl.

20. The compound of claim 19 , wherein R 12 is benzyl.

21. The compound of claim 18 , wherein R 12 is alkyl.

22. The compound of claim 18 , wherein R 12 is acetyl.

23. The compound of claim 18 , wherein R 12 is alkenyl.

24. The compound of claim 1 , wherein R 12 is hydrogen.

25. A compound selected from the group consisting of:

26. A pharmaceutical composition comprising a therapeutically effective amount of a compound of claim 1 or 25 , and a pharmaceutically acceptable carrier.

27. The compound of claim 1 , wherein said compound is:

28. A compound of Formula I:

wherein:

X is CHC(R 13 Y′Y), or CR 6′ R 6 ;

R 2″ is —C(O)NR 2 R 2′ ;

R 2 , R 2′ , R 4a , and R 4b are each independently hydrogen, alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, arylalkyl, aryl, heterocyclic, heteroaromatic or a prodrug moiety;

R 10 is alkyl, alkenyl, aryl, alkynyl, arylalkyl, acetyl, alkylcarbonyl, alkenylcarbonyl, arylcarbonyl, alkynylcarbonyl, alkyloxycarbonyl, alkenyloxycarbonyl, alkynyloxycarbonyl, aryloxycarbonyl, alkylaminocarbonyl, alkenylaminocarbonyl, alkynylaminocarbonyl, arylaminocarbonyl, alkylthiocarbonyl, alkenylthiocarbonyl, alkynylthiocarbonyl, arylthiocarbonyl, alkyloxythiocarbonyl, alkenyloxythiocarbonyl, alkynyloxythiocarbonyl, aryloxythiocarbonyl, alkylaminothiocarbonyl, alkenylaminothiocarbonyl, alkynylaminothiocarbonyl, arylaminothiocarbonyl, alkylthiothiocarbonyl, alkenylthiothiocarbonyl, alkynylthiothiocarbonyl, or arylthiothiocarbonyl;

R 3 , R 11 , R 12 , and R 12″ are each hydrogen;

R 4 and R 4′ are each independently NR 4a R 4b , alkyl, alkenyl, alkynyl, hydroxyl, halogen, hydrogen, or when taken together the oxygen of a carbonyl group;

R 5 is hydroxyl, hydrogen, thiol, alkanoyl, aroyl, alkaroyl, aryl, heteroaromatic, alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, arylalkyl, alkyl carbonyloxy, or aryl carbonyloxy;

R 6 and R 6′ are each independently hydrogen, methylene, absent, hydroxyl, halogen, thiol, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, or arylalkyl;

R 7 is amino;

R 8 is hydrogen;

R 9 is hydrogen;

R 12′ is OR 12 or NR 12 R 12″ ;

R 13 is hydrogen, hydroxy, alkyl, alkenyl, alkynyl, alkoxy, alkylthio, aryl, alkylsulfinyl, alkylsulfonyl, alkylamino, or arylalkyl;

Y′ and Y are each independently hydrogen, halogen, hydroxyl, cyano, sulfhydryl, amino, alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, or arylalkyl; or a pharmaceutically acceptable salt, ester or enantiomer thereof.

Assignments (4)
TERMINATION OF LIEN ON PATENTS Recorded Dec 23, 2014
From: MINTZ LEVIN COHN FERRIS GLOVSKY AND POPEO PC
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 034700/0377 →
RELEASE OF SECURITY INTEREST Recorded Oct 31, 2014
From: HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD., AS COLLATERAL AGENT
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 034113/0910 →
SECURITY INTEREST Recorded Mar 14, 2014
From: PARATEK PHARMACEUTICALS, INC.
To: HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD., AS COLLATERAL AGENT
Reel/Frame 032448/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2010
From: NELSON, MARK L.; OHEMENG, KWASI; BANDARAGE, UPUL; CHEN, JACKSON; ISMAIL, MOHAMED Y.; KIM, OAK K.
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 023990/0143 →